BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12842282)

  • 1. Absence of nalbuphine anti-analgesia in the rat.
    Khasar SG; Gear RW; Levine JD
    Neurosci Lett; 2003 Jul; 345(3):165-8. PubMed ID: 12842282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.
    Gear RW; Bogen O; Ferrari LF; Green PG; Levine JD
    Neuroscience; 2014 Jan; 257():139-48. PubMed ID: 24188792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans.
    Gear RW; Gordon NC; Miaskowski C; Paul SM; Heller PH; Levine JD
    Neurosci Lett; 2003 Nov; 351(1):5-8. PubMed ID: 14550900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain.
    Gear RW; Gordon NC; Hossaini-Zadeh M; Lee JS; Miaskowski C; Paul SM; Levine JD
    J Pain; 2008 Apr; 9(4):337-41. PubMed ID: 18201935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of morphine tolerance and withdrawal syndrome by coadministration of nalbuphine.
    Jang S; Kim H; Kim D; Jeong MW; Ma T; Kim S; Ho IK; Oh S
    Arch Pharm Res; 2006 Aug; 29(8):677-84. PubMed ID: 16964763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dimorphism in very low dose nalbuphine postoperative analgesia.
    Gear RW; Gordon NC; Miaskowski C; Paul SM; Heller PH; Levine JD
    Neurosci Lett; 2003 Mar; 339(1):1-4. PubMed ID: 12618286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic effect of MR2266 and MR2267 on morphine or nalbuphine analgesia at the spinal levels in rats.
    Kmieciak-Kołada K; Spiewak Z; Urbanowicz A; Pawłowski J; Herman ZS
    Pol J Pharmacol; 1995; 47(6):509-18. PubMed ID: 8868373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA; French AM
    Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    Pick CG; Paul D; Pasternak GW
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain.
    Gear RW; Miaskowski C; Gordon NC; Paul SM; Heller PH; Levine JD
    Pain; 1999 Nov; 83(2):339-45. PubMed ID: 10534607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-opioids produce significantly greater analgesia in women than in men.
    Gear RW; Miaskowski C; Gordon NC; Paul SM; Heller PH; Levine JD
    Nat Med; 1996 Nov; 2(11):1248-50. PubMed ID: 8898754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
    Pick CG; Peter Y; Schreiber S; Weizman R
    Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the analgesic interaction between intrathecal morphine and subcutaneous nalbuphine in the rat.
    Loomis CW; Penning J; Milne B
    Anesthesiology; 1989 Nov; 71(5):704-10. PubMed ID: 2817464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.